| Trial ID: | L3026 |
| Source ID: | NCT00354939
|
| Associated Drug: |
Insulin Glargine
|
| Title: |
Insulin Analogue With Continuous Glucose Monitoring System (CGMS) Measurement
|
| Acronym: |
SAFIR
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus Type 2
|
| Interventions: |
DRUG: Insulin glargine
|
| Outcome Measures: |
Primary: Frequency of subjects with conventionally detected hypoglycemia |
|
| Sponsor/Collaborators: |
Sponsor: Sanofi
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
480
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2003-10
|
| Completion Date: |
2004-03
|
| Results First Posted: |
|
| Last Update Posted: |
2010-08-31
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00354939
|
